Oncogenes, Molecular Medicine, and Bone Marrow Transplantation

Nobuko Hijiya, Alan M. Gewirtz*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Retroviruses are known to carry specific genes that are likely to be responsible for induction of the malignant phenotype in the cells they infect. These genes, termed viral oncogenes (v-onc), have subsequently been shown to be derived from highly conserved, normal cellular genes commonly referred to as proto-oncogenes (c-onc). Proto-oncogenes are thought to be intimately involved in the processes of cell proliferation and differentiation. Therefore, any c-onc amplification, mutation, structural alteration, or change in transcriptional regulation might lead to, or be associated with, induction of a malignant phenotype. Targeted disruption of these genes may therefore be of therapeutic value. We discuss the role of antisense DNA in carrying out such therapy.

Original languageEnglish (US)
Pages (from-to)369-378
Number of pages10
JournalJournal of Hematotherapy and Stem Cell Research
Volume1
Issue number4
DOIs
StatePublished - 1992

ASJC Scopus subject areas

  • Immunology
  • Hematology

Fingerprint Dive into the research topics of 'Oncogenes, Molecular Medicine, and Bone Marrow Transplantation'. Together they form a unique fingerprint.

Cite this